Weight
Tirzepatide
Dual GIP and GLP-1 receptor agonist studied for insulin regulation and metabolic balance.
Medical Disclaimer: These products are not intended to diagnose, treat, cure, or prevent any disease. Consult your physician or qualified healthcare provider before starting any new supplement or wellness protocol.
Purchase option
Tirzepatide is a novel dual agonist that activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously. This dual mechanism provides a unique research model for studying how combined incretin signaling affects insulin secretion, glucagon suppression, and energy utilization. Each vial contains 10mg of lyophilized tirzepatide at ≥99% purity.
What it does
- Dual GIP + GLP-1 receptor agonist
- 10mg lyophilized powder — ≥99% purity verified
- Unique tool for incretin signaling research
- Third-party tested by independent ISO-certified lab
- Cold-chain shipped with Certificate of Analysis
How to use
Reconstitute with 1–2mL bacteriostatic water. Gently swirl until fully dissolved.
Store lyophilized at 2–8°C. Once reconstituted, refrigerate and use within 30 days.
For research use only. Not intended for human consumption.
What’s in the box
- 1 lyophilized vial
- Certificate of Analysis
- Desiccant pack
Product FAQ
Semaglutide is a single GLP-1 agonist; tirzepatide activates both GIP and GLP-1 receptors. This dual action makes it a distinct research tool for studying combined incretin pathway effects.
≥99% purity, verified by independent HPLC and mass spectrometry. Certificate of Analysis provided with every shipment.
Combination research is at the discretion of the researcher. Consult relevant literature before combining research compounds.